HANMI PHARM. CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 303,500 KRW | -1.94% |
|
-4.11% | -13.90% |
| 05-08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
| 05-01 | Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.87B | ||||||
| 44.35B | ||||||
| 15.08B | ||||||
| 14.37B | ||||||
| 13.06B | ||||||
| 6.79B | - | - | - | - | - |
